Neutra Corporation (NTRR) financial statements (2023 and earlier)

Company profile

Business Address 54 SUGAR CREEK CENTER BLVD.
SUGAR LAND, TX 77478
State of Incorp. WY
Fiscal Year End January 31
SIC 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

10/31/2021
TTM
1/31/2021
1/31/2020
1/31/2019
1/31/2018
1/31/2017
1/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 23177   0
Cash and cash equivalents 23177   0
Receivables 0     
Inventory, net of allowances, customer advances and progress billings  4    
Inventory  4    
Other undisclosed current assets 2216412  
Total current assets: 2518216412 0
Noncurrent Assets
Property, plant and equipment 166     
Total noncurrent assets: 166     
TOTAL ASSETS: 19118216412 0
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 426411458458471391
Interest and dividends payable 1841741345514 
Other undisclosed accounts payable and accrued liabilities 242237324403458391
Debt  236214756 
Due to related parties 1321328484847
Other undisclosed current liabilities 4444666655917 
Total current liabilities: 1,0021,0321,269748628398
Noncurrent Liabilities
Long-term debt and lease obligation    172918
Long-term debt, excluding current maturities    172918
Liabilities, other than long-term debt    121911
Accounts payable and accrued liabilities    121911
Total noncurrent liabilities:    294728
Total liabilities: 1,0021,0321,269777676426
Stockholders' equity
Stockholders' equity attributable to parent, including: (967)(849)(1,106)(764)(676)(425)
Preferred stock   1111
Common stock 1,49361634732
Additional paid in capital 7,4288,0927,7235,6625,2364,619
Accumulated deficit (10,140)(9,559)(8,864)(6,434)(5,915)(5,047)
Other undisclosed stockholders' equity attributable to parent 2522    
Other undisclosed stockholders' equity 156     
Total stockholders' equity: (811)(849)(1,106)(764)(676)(425)
TOTAL LIABILITIES AND EQUITY: 19118216412 0

Income statement (P&L) ($ in thousands)

10/31/2021
TTM
1/31/2021
1/31/2020
1/31/2019
1/31/2018
1/31/2017
1/31/2016
Revenues 1061   
Other income   1   
Cost of revenue
(Cost of Goods and Services Sold)
 (43)     
Gross profit: (33)61   
Operating expenses (445)(401)(1,709)(164)(371)(1,036)
Other undisclosed operating loss   (1)   
Operating loss: (479)(394)(1,709)(164)(371)(1,036)
Nonoperating expense (60)(301)(720)(355)(497)(407)
Interest and debt expense 6174(721)(355)(497)(402)
Net loss: (477)(621)(3,150)(874)(1,365)(1,844)
Other undisclosed net income (loss) attributable to parent (61)(74)721355497402
Net loss attributable to parent: (539)(696)(2,429)(519)(868)(1,443)
Other undisclosed net loss available to common stockholders, basic (42)     
Net loss available to common stockholders, diluted: (581)(696)(2,429)(519)(868)(1,443)

Comprehensive Income ($ in thousands)

10/31/2021
TTM
1/31/2021
1/31/2020
1/31/2019
1/31/2018
1/31/2017
1/31/2016
Net loss: (477)(621)(3,150)(874)(1,365)(1,844)
Comprehensive loss, net of tax, attributable to parent: (477)(621)(3,150)(874)(1,365)(1,844)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: